Nicaragua vs Saudi Arabia: The number of people with susceptibility test result for rifampicin
Nicaragua
627
in 2021
Saudi Arabia
591
in 2021
Nicaragua rank
74th
Saudi Arabia rank
77th
The number of people with susceptibility test result for rifampicin over time
- Nicaragua
- Saudi Arabia
How they compare
Nicaragua currently reports 627 against 591 in Saudi Arabia, a difference of 36.
That makes Nicaragua's figure about 1.1 times Saudi Arabia's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Saudi Arabia ahead.
Nicaragua ranks 74th and Saudi Arabia ranks 77th of 155 countries.
Across the 2 decades both report, Nicaragua averaged higher in 1 and Saudi Arabia in 1.
Head to head by decade
| Decade | Nicaragua | Saudi Arabia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 675.33 | 1,131 | 455.67 | Saudi Arabia |
| 2020s | 944.5 | 590.5 | 354 | Nicaragua |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Nicaragua or Saudi Arabia?
- Nicaragua, at 627 against 591 in Saudi Arabia as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Nicaragua and Saudi Arabia?
- 36, with Nicaragua ahead.
- How many years of comparable data are there for Nicaragua and Saudi Arabia?
- 5 years are reported by both, from 2017 to 2021.
- How do Nicaragua and Saudi Arabia rank globally for the number of people with susceptibility test result for rifampicin?
- Nicaragua ranks 74th and Saudi Arabia ranks 77th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.